Heterocyclic Janus Kinase 3 inhibitors
US8163767B2 · kind B2 · utility
32Cited by
5References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 13, 2006 |
| Grant date | Apr 24, 2012 |
| Priority date | — |
| Expiry date | Jul 6, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to compound of the formula (I) or its salt, wherein —R1, —R2, —R3, —R4, —R5, -M-, —X— and —Y═ are as defined in the description, their use of as, medicament, the process for their preparation and use for the treatment of JAK3 mediated diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.